217 related articles for article (PubMed ID: 19620783)
1. The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells.
Rüder C; Höpken UE; Wolf J; Mittrücker HW; Engels B; Erdmann B; Wollenzin S; Uckert W; Dörken B; Rehm A
J Clin Invest; 2009 Aug; 119(8):2184-203. PubMed ID: 19620783
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C delta localizes to secretory lysosomes in CD8+ CTL and directly mediates TCR signals leading to granule exocytosis-mediated cytotoxicity.
Ma JS; Haydar TF; Radoja S
J Immunol; 2008 Oct; 181(7):4716-22. PubMed ID: 18802074
[TBL] [Abstract][Full Text] [Related]
3. EBAG9 tempers lymphocyte killing activity.
Ménasché G; de Saint Basile G
J Clin Invest; 2009 Aug; 119(8):2136-40. PubMed ID: 19620775
[TBL] [Abstract][Full Text] [Related]
4. Natural Killer Cell Group 7 Sequence in Cytotoxic Cells Optimizes Exocytosis of Lytic Granules Essential for the Perforin-Dependent, but Not Fas Ligand-Dependent, Cytolytic Pathway.
Morikawa Y; Murakami M; Kondo H; Nemoto N; Iwabuchi K; Eshima K
Immunohorizons; 2021 Apr; 5(4):234-245. PubMed ID: 33911019
[TBL] [Abstract][Full Text] [Related]
5. Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells.
Shen DT; Ma JS; Mather J; Vukmanovic S; Radoja S
J Leukoc Biol; 2006 Oct; 80(4):827-37. PubMed ID: 16891618
[TBL] [Abstract][Full Text] [Related]
6. EBAG9 silencing exerts an immune checkpoint function without aggravating adverse effects.
Wirges A; Bunse M; Joedicke JJ; Blanc E; Gudipati V; Moles MW; Shiku H; Beule D; Huppa JB; Höpken UE; Rehm A
Mol Ther; 2022 Nov; 30(11):3358-3378. PubMed ID: 35821635
[TBL] [Abstract][Full Text] [Related]
7. CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis.
Radoja S; Saio M; Schaer D; Koneru M; Vukmanovic S; Frey AB
J Immunol; 2001 Nov; 167(9):5042-51. PubMed ID: 11673513
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of synaptotagmin VII in CTLs.
Fowler KT; Andrews NW; Huleatt JW
J Immunol; 2007 Feb; 178(3):1498-504. PubMed ID: 17237398
[TBL] [Abstract][Full Text] [Related]
9. The exocytosis of lytic granules is impaired in Vti1b- or Vamp8-deficient CTL leading to a reduced cytotoxic activity following antigen-specific activation.
Dressel R; Elsner L; Novota P; Kanwar N; Fischer von Mollard G
J Immunol; 2010 Jul; 185(2):1005-14. PubMed ID: 20543108
[TBL] [Abstract][Full Text] [Related]
10. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway.
Isaaz S; Baetz K; Olsen K; Podack E; Griffiths GM
Eur J Immunol; 1995 Apr; 25(4):1071-9. PubMed ID: 7737276
[TBL] [Abstract][Full Text] [Related]
11. LYST controls the biogenesis of the endosomal compartment required for secretory lysosome function.
Sepulveda FE; Burgess A; Heiligenstein X; Goudin N; Ménager MM; Romao M; Côte M; Mahlaoui N; Fischer A; Raposo G; Ménasché G; de Saint Basile G
Traffic; 2015 Feb; 16(2):191-203. PubMed ID: 25425525
[TBL] [Abstract][Full Text] [Related]
12. EBAG9 adds a new layer of control on large dense-core vesicle exocytosis via interaction with Snapin.
Rüder C; Reimer T; Delgado-Martinez I; Hermosilla R; Engelsberg A; Nehring R; Dörken B; Rehm A
Mol Biol Cell; 2005 Mar; 16(3):1245-57. PubMed ID: 15635093
[TBL] [Abstract][Full Text] [Related]
13. A role for endobrevin/VAMP8 in CTL lytic granule exocytosis.
Loo LS; Hwang LA; Ong YM; Tay HS; Wang CC; Hong W
Eur J Immunol; 2009 Dec; 39(12):3520-8. PubMed ID: 19830729
[TBL] [Abstract][Full Text] [Related]
14. Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicity.
Sutton VR; Brennan AJ; Ellis S; Danne J; Thia K; Jenkins MR; Voskoboinik I; Pejler G; Johnstone RW; Andrews DM; Trapani JA
FEBS J; 2016 Mar; 283(5):947-61. PubMed ID: 26756195
[TBL] [Abstract][Full Text] [Related]
15. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
16. Syntaxin7 is required for lytic granule release from cytotoxic T lymphocytes.
Pattu V; Qu B; Marshall M; Becherer U; Junker C; Matti U; Schwarz EC; Krause E; Hoth M; Rettig J
Traffic; 2011 Jul; 12(7):890-901. PubMed ID: 21438968
[TBL] [Abstract][Full Text] [Related]
17. Intracellular estrogen receptor-binding fragment-associated antigen 9 exerts in vivo tumor-promoting effects via its coiled-coil region.
Maeyama Y; Otsu M; Kubo S; Yamano T; Iimura Y; Onodera M; Kondo S; Sakiyama Y; Ariga T
Int J Oncol; 2011 Jul; 39(1):41-9. PubMed ID: 21573489
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinoma.
Ogushi T; Takahashi S; Takeuchi T; Urano T; Horie-Inoue K; Kumagai J; Kitamura T; Ouchi Y; Muramatsu M; Inoue S
Cancer Res; 2005 May; 65(9):3700-6. PubMed ID: 15867365
[TBL] [Abstract][Full Text] [Related]
19. Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice.
Haddad EK; Wu X; Hammer JA; Henkart PA
J Cell Biol; 2001 Feb; 152(4):835-42. PubMed ID: 11266473
[TBL] [Abstract][Full Text] [Related]
20. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis.
Baetz K; Isaaz S; Griffiths GM
J Immunol; 1995 Jun; 154(11):6122-31. PubMed ID: 7751653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
